CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Editor-in-Chief:

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Back

Become EABM
Become Reviewer



Meet the Editorial Board free to download

Volume:14   Issue: 2
Pp: 151-151
Mohammad Amjad Kamal
DOI: 10.2174/187152731402150305113014



Commentary (Changes of Synaptic Plasticity in Multiple Sclerosis) promotion: free to download

Volume:14   Issue: 2
Pp: 152-154
Ti-Fei Yuan, Chunlei Shan and Oscar Arias-Carrion
DOI: 10.2174/1871527313666141114203620



Editorial (Thematic Issue: MiRNAcles in the Brain: What to Wish and What to Fear) free to download

Volume:14   Issue: 2
Pp: 155-156
Stephen D. Skaper and Cinzia Volonte
DOI: 10.2174/187152731402150305113941

The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators

Volume:14   Issue: 2
Pp: 157-167
Wouter W. Kamphuis, Claudio Derada Troletti, Aric Reijerkerk, Ignacio A. Romero and Helga E. de Vries
DOI: 10.2174/1871527314666150116125246

MicroRNA Landscape in Alzheimer’s Disease

Volume:14   Issue: 2
Pp: 168-175
Carlo Cogoni, Francesca Ruberti and Christian Barbato
DOI: 10.2174/1871527314666150116123305

MicroRNAs: Newcomers into the ALS Picture

Volume:14   Issue: 2
Pp: 194-207
Cinzia Volonte, Savina Apolloni and Chiara Parisi
DOI: 10.2174/1871527314666150116125506

The Emerging Role of MicroRNA in Schizophrenia

Volume:14   Issue: 2
Pp: 208-221
Viviana Caputo, Andrea Ciolfi, Simone Macri and Antonio Pizzuti
DOI: 10.2174/1871527314666150116124253

MicroRNAs in Glioblastoma: Role in Pathogenesis and Opportunities for Targeted Therapies

Volume:14   Issue: 2
Pp: 222-238
Pedro M. Costa, Ana L. Cardoso, Miguel Mano and Maria C. Pedroso de Lima
DOI: 10.2174/1871527314666150116123610

MicroRNAs: Emerging Role in the Endogenous μ Opioid System

Volume:14   Issue: 2
Pp: 239-250
Massmo Barbierato, Morena Zusso, Stephen D. Skaper and Pietro Giusti
DOI: 10.2174/1871527314666150116123932

Interferon-γ-Induced Neurotoxicity of Human Astrocytes

Volume:14   Issue: 2
Pp: 251-256
Sadayuki Hashioka, Edith G. McGeer, Tsuyoshi Miyaoka, Rei Wake, Jun Horiguchi and Patrick L. McGeer
DOI: 10.2174/1871527314666150217122305

Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?

Volume:14   Issue: 2
Pp: 257-269
Apostolos Safouris, Theodora Psaltopoulou, Theodoros N. Sergentanis, Eleni Boutati, Elisabeth Kapaki and Georgios Tsivgoulis
DOI: 10.2174/1871527314666150217123147

Potential Targets for the Development of Novel Antidepressants: Future Perspectives

Volume:14   Issue: 2
Pp: 270-281
Vishnu N. Thakare and Bhoomika M. Patel
DOI: 10.2174/1871527313666140806121648

Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model

Volume:14   Issue: 2
Pp: 295-302
Jitendra Kumar, Kyung-Chae Park, Anjali Awasthi and Birendra Prasad
DOI: 10.2174/1871527314666150116110212